2022
DOI: 10.1038/s41568-022-00459-0
|View full text |Cite
|
Sign up to set email alerts
|

Targeting ferroptosis as a vulnerability in cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
639
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 826 publications
(661 citation statements)
references
References 203 publications
5
639
0
Order By: Relevance
“…Ferroptosis recently emerged as an iron-dependent, non-apoptotic form of regulated cell death particularly relevant to cancer therapy with implications in response to chemotherapy, radiotherapy and immunotherapy [67][68][69] . However, no selective GPX4 inhibitor is currently available for patient care.…”
Section: Discussionmentioning
confidence: 99%
“…Ferroptosis recently emerged as an iron-dependent, non-apoptotic form of regulated cell death particularly relevant to cancer therapy with implications in response to chemotherapy, radiotherapy and immunotherapy [67][68][69] . However, no selective GPX4 inhibitor is currently available for patient care.…”
Section: Discussionmentioning
confidence: 99%
“…However, SLC40A1, encoding ferroportin-1, was upregulated in our analysis ( Figure 1C ). Theoretically, when ferroptosis occurs in septic patients, SLC40A1-mediated iron export was inhibited ( 33 ). However, SLC40A1 should be increased from a clinical or homeostasis view.…”
Section: Discussionmentioning
confidence: 99%
“…So far the subcellular localization of the GCH1/BH4/DHFR axis is not fully-illustrated. 32 The cyst(e)ine/GSH/GPX4 axis is the first discovered and most extensively studied pathway in suppressing ferroptosis. 33 GPX4 is a selenoprotein that catalyzes the reduction and detoxification of lipid ROS production in mammalian cells.…”
Section: Lpo-mediated Cytotoxicitymentioning
confidence: 99%